NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
Back to search
Official data from USPTO
PHARMA NOBIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMA NOBIS
ST13
US500000099351974Class
40, 42
Filing
99351974
Registration
8228516
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
04/28/2026
Trademark type
Word
Nice classes
40, 42
Filing date
08/22/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/02/2022
First use in commerce
02/02/2022
Drawing code
4
Owner type
16
Owner location
Texarkana, TX, US
Examiner
BHANOT, KAPIL KUMAR
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Pharma Nobis, LLC
Representatives
Michelle Rosenberg OUTSIDE GENERAL COUNSEL LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing in the field of consumer health and beauty care productsover-the-counter medicationsanalgesicsantacidscosmeticsdigestivesear care productspain relief productsexternal pain productsfirst aid productsskin care productswound care products; Custom manufacturing of pharmaceuticals
Class 42
Laboratory services for the production of pharmaceutical products; Development of products for others; Development of products for others in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/10/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/10/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/10/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/10/2026
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/16/2026
GPRA
PRIORITY ACTION E-MAILED
01/16/2026
CPRA
PRIORITY ACTION WRITTEN
01/16/2026
DOCK
ASSIGNED TO EXAMINER
01/07/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/24/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/22/2025
NWAP
NEW APPLICATION ENTERED
08/22/2025
Continuous trademark protection
Get notified about every new filing that threatens PHARMA NOBIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.